We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Atomoxetine and bupropion interaction.
- Authors
Lam, Y. W. Francis
- Abstract
In addition to its approved use for the treatment of patients with attention‐deficit hyperactivity disorder (ADHD), the selective norepinephrine reuptake inhibitor atomoxetine is sometimes used off‐label as an adjunctive therapy for patients with major depressive disorder. Bupropion, a norepinephrine/dopamine reuptake inhibitor approved for the treatment of depression, is also used off‐label for ADHD. Bupropion is a potent inhibitor of CYP2D6, the cytochrome P‐450 isoenzyme responsible for mediating the primary hydroxylation pathway of atomoxetine to its active metabolite 4‐hydroxy‐atomoxetine.
- Subjects
DRUG therapy for psychoses; THERAPEUTICS; HOSPITAL emergency services; PSYCHOSES; QUETIAPINE; ATOMOXETINE; TREATMENT effectiveness; AFFECTIVE disorders; DRUG interactions; BUPROPION; ANXIETY disorders; SEIZURES (Medicine)
- Publication
Brown University Psychopharmacology Update, 2024, Vol 35, Issue 3, p2
- ISSN
1068-5308
- Publication type
Article
- DOI
10.1002/pu.31131